ZL-1310 Clinical Trials (2026): 4 Studies for SCLC & Small-cell Lung Cancer

Where to Participate: All ZL-1310 Trial Sites in the U.S. (53 sites across 19 states)

Every actively recruiting ZL-1310trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

ZL-1310 clinical trials at a glance: phase × recruitment status

Recruiting ZL-1310 clinical trials (4)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

ZL-1310 clinical trials by indication

ZL-1310 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All ZL-1310 trials (4)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

ZL-1310 clinical trials: frequently asked questions

How many ZL-1310 clinical trials are there?

4 ZL-1310 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants.

Are ZL-1310 clinical trials recruiting in 2026?

Yes — 4 ZL-1310 trials are actively recruiting in 2026, with 53 U.S. sites across 19 states. See the recruiting trials and the per-state site list further down this page.

What conditions is ZL-1310 being studied for?

ZL-1310 is being studied for SCLC, Small-cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors. The trials are grouped by indication on this page.

What phase is ZL-1310 in?

ZL-1310 clinical trials span 1 Phase 3, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors ZL-1310 clinical trials?

The lead sponsor across the most ZL-1310 trials is Zai Lab (Shanghai) Co., Ltd., with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ZL-1310as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.